ATE258310T1 - Testverfahren für collagenpeptid - Google Patents

Testverfahren für collagenpeptid

Info

Publication number
ATE258310T1
ATE258310T1 AT98938343T AT98938343T ATE258310T1 AT E258310 T1 ATE258310 T1 AT E258310T1 AT 98938343 T AT98938343 T AT 98938343T AT 98938343 T AT98938343 T AT 98938343T AT E258310 T1 ATE258310 T1 AT E258310T1
Authority
AT
Austria
Prior art keywords
gly
hyp
ala
level
test methods
Prior art date
Application number
AT98938343T
Other languages
English (en)
Inventor
Stephen M Krane
Michael H Byrne
Hsin-Shan Julia Ju
Scott D Leigh
Original Assignee
Metra Biosystems Inc
Massachusetts Gen Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metra Biosystems Inc, Massachusetts Gen Hospital filed Critical Metra Biosystems Inc
Application granted granted Critical
Publication of ATE258310T1 publication Critical patent/ATE258310T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/108—Osteoporosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT98938343T 1997-07-31 1998-07-31 Testverfahren für collagenpeptid ATE258310T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5436997P 1997-07-31 1997-07-31
PCT/US1998/016224 WO1999006840A1 (en) 1997-07-31 1998-07-31 Collagen-peptide assay method

Publications (1)

Publication Number Publication Date
ATE258310T1 true ATE258310T1 (de) 2004-02-15

Family

ID=21990562

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98938343T ATE258310T1 (de) 1997-07-31 1998-07-31 Testverfahren für collagenpeptid

Country Status (9)

Country Link
US (1) US5972623A (de)
EP (1) EP1010007B1 (de)
JP (1) JP2001512143A (de)
AT (1) ATE258310T1 (de)
AU (1) AU752227B2 (de)
CA (1) CA2297555A1 (de)
DE (1) DE69821246T2 (de)
ES (1) ES2214722T3 (de)
WO (1) WO1999006840A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050281821A1 (en) * 1999-01-06 2005-12-22 Flavia Pernasetti Method and composition for angiogenesis inhibition
ES2333845T3 (es) * 1999-01-06 2010-03-02 University Of Southern California Metodo y composicion para la inhibicion de la angiogenesis.
GB9907234D0 (en) * 1999-03-29 1999-05-26 Isis Innovation Drug assay
CA2379373A1 (en) * 1999-07-13 2001-01-18 University Of Southern California Novel method and composition for inhibition of angiogenesis using antagonists based on mmp-9 and .beta.1 integrins
JP2004510981A (ja) 2000-10-03 2004-04-08 ロウェット、リサーチ、インスティテュート ピロール含有生体化合物の測定方法およびピロール含有生体化合物
US7365167B2 (en) 2001-11-26 2008-04-29 Cell Matrix, Inc. Humanized collagen antibodies and related methods
US7390885B2 (en) 2001-11-26 2008-06-24 Cell Matrix, Inc. Humanized collagen antibodies and related methods
US7491691B2 (en) 2002-05-03 2009-02-17 Sindrey Dennis R Connective tissue stimulating peptides
US7488792B2 (en) 2002-08-28 2009-02-10 Burnham Institute For Medical Research Collagen-binding molecules that selectively home to tumor vasculature and methods of using same
US20050124071A1 (en) * 2003-09-30 2005-06-09 Kraus Virginia B. Methods and compositions for diagnosing musculoskeletal, arthritic and joint disorders by biomarker dating
WO2005079508A2 (en) * 2004-02-17 2005-09-01 Cancervax Corporation Method and composition for angiogenesis inhibition
US20070048325A1 (en) * 2005-08-24 2007-03-01 Dennis Van Epps Combination therapies for inhibiting integrin-extracellular matrix interactions
US8198979B2 (en) 2007-04-20 2012-06-12 Ink-Logix, Llc In-molded resistive and shielding elements
CN101809691B (zh) * 2007-04-20 2012-07-18 英克-罗吉克斯有限公司 模内成型的电容式开关
JP4490498B2 (ja) * 2008-09-30 2010-06-23 新田ゼラチン株式会社 疾病抑制剤
RU2581020C2 (ru) * 2009-12-22 2016-04-10 Селлдекс Терапьютикс, Инк. Композиции вакцин
US9383367B1 (en) 2010-12-07 2016-07-05 Chunli Liu Methods of detecting conjugation site-specific and hidden epitope/antigen
GB201721387D0 (en) * 2017-12-20 2018-01-31 Nordic Bioscience As Tumstatin assay

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4628027A (en) * 1982-05-19 1986-12-09 Molecular Engineering Associates, Ltd. Vitro diagnostic methods using monoclonal antibodies against connective tissue proteins
GB2208865B (en) * 1987-08-19 1991-12-11 Farmos Group Ltd Purified propeptide of procollagen type iii, antibody to the propeptide and assay method using the antibody.
US5300434A (en) * 1987-11-06 1994-04-05 Washington Research Foundation Hybridoma cell line producing an antibody to type-I collagen amino-terminal telopeptide
US5320970A (en) * 1987-11-06 1994-06-14 Washington Research Foundation Detection of collagen degradation in vivo
US4973666A (en) * 1987-11-06 1990-11-27 Washington Research Foundation Peptide fragments containing HP and LP cross-links
WO1989007761A1 (fr) * 1988-02-19 1989-08-24 Fuji Yakuhin Kogyo Kabushiki Kaisha Analyse immunologique selon un procede en sandwich du collagene humain de type iv
GB8815174D0 (en) * 1988-06-25 1988-08-03 Rowett Research Inst Method of monitoring collagen degradation
GB8929366D0 (en) * 1989-12-30 1990-02-28 Rowett Research Inst Method to detect connective tissue disorder in humans and animals
GB9014220D0 (en) * 1990-06-26 1990-08-15 Farmos Yhtymy Oy Method for the immunlolgical determinition of the carboxyterminal propeptide of type i procollagen
GB9105893D0 (en) * 1991-03-20 1991-05-08 Orion Yhtymae Oy Bone resorption assay based on a peptide liberated during collagen degradation
DE69332655T2 (de) * 1992-07-31 2003-11-27 Metra Biosystems, Inc. Verfahren und testsatz für pyridinium-crosslink-assay
CA2151234A1 (en) * 1992-12-17 1994-06-23 Viola T. Kung Serum pyridinium crosslinks assay
DE9300440U1 (de) * 1993-01-15 1993-03-18 Deutsche Baby-Farben GmbH, 6000 Frankfurt Faltschachtel
DK104093D0 (da) * 1993-09-17 1993-09-17 Osteometer A S Fremgangsmaade til bestemmelse af collagen-fragmenter i legemsvaesker, test-kit og midler til udoevelse af fremgangsmaaden og anvendelse af fremgangsmaaden til diagnosticering af lidelser associeret til collagen-metabolismen
GB9506050D0 (en) * 1995-03-24 1995-05-10 Osteometer A S Assaying collagen fragments in body fluids
ATE199185T1 (de) * 1994-10-17 2001-02-15 Osteometer Biotech As Einschätzung der fragmentierungsmuster von kollagen in körperflüssigkeiten und diagnose von mit dem kollagenmetabolismus zusammenhängenden störungen
US5731409A (en) * 1994-10-28 1998-03-24 Regents Of The University Of Minnesota Polypeptides with type I collagen activity
US5750647A (en) * 1995-05-19 1998-05-12 Washington Research Foundation Synthetic peptide analogs of NTx
EP0829724A1 (de) * 1996-09-17 1998-03-18 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Verfahren zum Nachweis von Kollagenabbau

Also Published As

Publication number Publication date
EP1010007B1 (de) 2004-01-21
DE69821246D1 (de) 2004-02-26
CA2297555A1 (en) 1999-02-11
ES2214722T3 (es) 2004-09-16
AU8688898A (en) 1999-02-22
AU752227B2 (en) 2002-09-12
US5972623A (en) 1999-10-26
DE69821246T2 (de) 2004-11-04
WO1999006840A1 (en) 1999-02-11
EP1010007A1 (de) 2000-06-21
JP2001512143A (ja) 2001-08-21

Similar Documents

Publication Publication Date Title
ATE258310T1 (de) Testverfahren für collagenpeptid
DK104093D0 (da) Fremgangsmaade til bestemmelse af collagen-fragmenter i legemsvaesker, test-kit og midler til udoevelse af fremgangsmaaden og anvendelse af fremgangsmaaden til diagnosticering af lidelser associeret til collagen-metabolismen
ATE230487T1 (de) Verfahren zur frühen diagnose von carcinomen
ATE155820T1 (de) Prüfung zur vorhersage des ergebnisses von ivf
BR9711869B1 (pt) mÉtodo e kit para coletar amostras de espÉcimes lÍquidas para teste analÍtico.
NO331148B1 (no) Anvendelse av et monoklonalt eller polyklonalt antistoff, samt fremgangsmate og kit for in vitro diagnose.
DK0682256T3 (da) Fremgangsmåde til en vivo-påvisning af collagennedbrydning
DE69937368D1 (de) Nachweis von erkrankungen der nieren und behandlung
ATE111228T1 (de) Verfahren zur überwachung des kollagenabbaus.
ES2152531T3 (es) Prueba para determinar el riesgo de trombosis.
DE69934324D1 (de) Behandlung von entzündungskrankheiten
FI923025A0 (fi) Diagnostinen menetelmä synnytysajankohdan ennustamiseksi sekä siihen käytettävä reagenssipakkaus
ID19063A (id) Pereaksi peptida untuk deteksi cytomegalovirus (cmv)
DK0747481T3 (da) Epstein-Barr-viruspeptider og antistoffer mod disse peptider
EP1476757A4 (de) Verfahren und kit zur krebsvorhersage
DE60035267D1 (de) Verfahren zur analyse der menge an intraabdominalem fettgewebe
EP1757704A3 (de) Methoden zur Erkennung von Mutationene in Verbindung mit hypertropher Kardiomyopathie
ATE173830T1 (de) Verfahren zur bestimmung der quantität extrazellulärer bpi in körperflüssigkeiten
DE69132144D1 (de) Menschliche phospholipase aktivierender proteinteil
ATE405829T1 (de) Test für haptoglobin
NO983984L (no) Disintegrin-metalloprotease samt anvendelse derav
SE9602234D0 (sv) A novel diagnostic method utilizing ECP, and reagents to be used in the methods
DE60216482D1 (de) Zusammensetzungen und verfahren zum bestimmen von aa4rp
NO994056L (no) Anvendelse av disintegrin metalloprotease samt mutanter og fragmenter derav
RU2000123728A (ru) Способы и составы для диагностики гепатомы

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties